201 related articles for article (PubMed ID: 30242850)
1. Pharmacokinetics of harpagoside in horses after intragastric administration of a Devil's claw (Harpagophytum procumbens) extract.
Axmann S; Hummel K; Nöbauer K; Razzazi-Fazeli E; Zitterl-Eglseer K
J Vet Pharmacol Ther; 2019 Jan; 42(1):37-44. PubMed ID: 30242850
[TBL] [Abstract][Full Text] [Related]
2. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
Romiti N; Tramonti G; Corti A; Chieli E
Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
[TBL] [Abstract][Full Text] [Related]
4. Harpagoside Content in Devil's Claw Extracts.
Kondamudi N; Turner MW; McDougal OM
Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
Inaba K; Murata K; Naruto S; Matsuda H
J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
[TBL] [Abstract][Full Text] [Related]
6. The Fight against Infection and Pain: Devil's Claw (
Gxaba N; Manganyi MC
Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
[No Abstract] [Full Text] [Related]
7. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo.
Loew D; Möllerfeld J; Schrödter A; Puttkammer S; Kaszkin M
Clin Pharmacol Ther; 2001 May; 69(5):356-64. PubMed ID: 11372004
[TBL] [Abstract][Full Text] [Related]
8. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
Hostanska K; Melzer J; Rostock M; Suter A; Saller R
J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
[TBL] [Abstract][Full Text] [Related]
9. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
Anauate MC; Torres LM; de Mello SB
Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
[TBL] [Abstract][Full Text] [Related]
10. Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats.
Joshi K; Parrish A; Grunz-Borgmann EA; Gerkovich M; Folk WR
BMC Complement Med Ther; 2020 Jan; 20(1):9. PubMed ID: 32020872
[TBL] [Abstract][Full Text] [Related]
11. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.).
Wegener T; Lüpke NP
Phytother Res; 2003 Dec; 17(10):1165-72. PubMed ID: 14669250
[TBL] [Abstract][Full Text] [Related]
12. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
[TBL] [Abstract][Full Text] [Related]
13. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
Abdelouahab N; Heard C
J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
[TBL] [Abstract][Full Text] [Related]
14. Rapid measurement and evaluation of the effect of drying conditions on harpagoside content in Harpagophytum procumbens (devil's claw) root.
Joubert E; Manley M; Gray BR; Schulz H
J Agric Food Chem; 2005 May; 53(9):3493-502. PubMed ID: 15853393
[TBL] [Abstract][Full Text] [Related]
15. Harpagoside: from Kalahari Desert to pharmacy shelf.
Georgiev MI; Ivanovska N; Alipieva K; Dimitrova P; Verpoorte R
Phytochemistry; 2013 Aug; 92():8-15. PubMed ID: 23642455
[TBL] [Abstract][Full Text] [Related]
16. Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety.
Brien S; Lewith GT; McGregor G
J Altern Complement Med; 2006 Dec; 12(10):981-93. PubMed ID: 17212570
[TBL] [Abstract][Full Text] [Related]
17. Estimation of the relative antiinflammatory efficacies of six commercial preparations of Harpagophytum procumbens (Devil's Claw).
Ouitas NA; Heard C
Phytother Res; 2010 Mar; 24(3):333-8. PubMed ID: 19610038
[TBL] [Abstract][Full Text] [Related]
18. Quality Assessment of Commercial Spagyric Tinctures of
Avato P; Argentieri MP
Molecules; 2019 Jun; 24(12):. PubMed ID: 31212908
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical properties of harpagoside and its in vitro release from Harpagophytum procumbens extract tablets.
Chrubasik S; Sporer F; Dillmann-Marschner R; Friedmann A; Wink M
Phytomedicine; 2000 Jan; 6(6):469-73. PubMed ID: 10715851
[TBL] [Abstract][Full Text] [Related]
20. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease.
Whitehouse LW; Znamirowska M; Paul CJ
Can Med Assoc J; 1983 Aug; 129(3):249-51. PubMed ID: 6407745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]